BAM-15 30mg/mL 30mL
Mitochondrial Uncoupler for Fat Loss Without Cardiovascular Risk
BAM-15 is a mitochondrial proton carrier that uncouples respiration from ATP production, burning fat as heat without the cardiac toxicity associated with classic uncouplers like DNP. Reduces fat mass while preserving lean mass in animal studies.
Mitochondrial Uncoupler for Fat Loss Without Cardiovascular Risk
BAM-15 (BAM15) is a BAM-class mitochondrial uncoupler that increases proton conductance across the inner mitochondrial membrane, dissipating the proton gradient as heat and dramatically increasing fat oxidation without affecting heart rate or causing hyperthermia in research doses.
As one of the most studied compounds in the metabolic & fat loss research space, BAM-15 has attracted sustained scientific interest across Mitochondrial uncoupling research, Safe fat loss mechanism studies, Insulin resistance research. Peer-reviewed evidence indicates that reduces fat mass without lean mass loss in mice, which has positioned BAM-15 as a reference standard for researchers exploring mitochondrial uncoupling research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
BAM-15 Documented Benefits: 3 Documented Mechanisms
Safe Mitochondrial Uncoupling
Burns calories as heat via mitochondrial uncoupling without DNP's cardiac toxicity.
Selective Fat Loss
Reduces fat mass while preserving lean muscle mass in diet-induced obesity models.
Insulin Sensitivity
Improves insulin sensitivity and reduces hepatic fat alongside body fat reduction.
How BAM-15 Works: Molecular Mechanism & Pathway
Mitochondrial inner membrane proton carrier increasing uncoupled respiration, dissipating the proton gradient as heat and dramatically elevating cellular metabolic rate without affecting heart rate.
The 3 primary research pathways identified for BAM-15 — Safe Mitochondrial Uncoupling, Selective Fat Loss, Insulin Sensitivity — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that does not increase heart rate unlike DNP, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, BAM-15's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
BAM-15 is routinely studied alongside AICAR and BAM-15 in metabolic & fat loss-focused compound panels. Researchers investigating mitochondrial uncoupling research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that improves insulin sensitivity in obesity models has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All BAM-15 research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Reduces fat mass without lean mass loss in mice
- Does not increase heart rate unlike DNP
- Improves insulin sensitivity in obesity models
Ideal For
- Mitochondrial uncoupling research
- Safe fat loss mechanism studies
- Insulin resistance research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on BAM-15. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Reduces fat mass without lean mass loss in mice
Does not increase heart rate unlike DNP
Improves insulin sensitivity in obesity models
Third-Party Verified Every Batch
Each vial of BAM-15 is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
